financetom
Business
financetom
/
Business
/
Five9 Insider Sold Shares Worth $381,251, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Five9 Insider Sold Shares Worth $381,251, According to a Recent SEC Filing
Sep 6, 2024 3:12 PM

05:52 PM EDT, 09/06/2024 (MT Newswires) -- Michael Burkland, Chief Executive Officer, on September 04, 2024, sold 12,595 shares in Five9 ( FIVN ) for $381,251. Following the Form 4 filing with the SEC, Burkland has control over a total of 386,514 shares of the company, with 253,488 shares held directly and 133,026 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1288847/000128884724000137/xslF345X05/wk-form4_1725659238.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Campbell Soup Positioned For Largely In-Line Second Quarter, RBC Says
Campbell Soup Positioned For Largely In-Line Second Quarter, RBC Says
Mar 5, 2024
04:02 PM EST, 03/05/2024 (MT Newswires) -- Campbell Soup ( CPB ) is positioned for a largely in-line fiscal second quarter with possible top-line upside amid strong January soup trends, though the consumer packaged food industry remains challenged, RBC Capital Markets said Tuesday. Campbell's salty snacks category continues to slow and its soup business faces pressure from a trade-down to...
Nektar Therapeutics Begins Phase 2b Trial for Rezpegaldesleukin in Patients With Severe Alopecia Areata
Nektar Therapeutics Begins Phase 2b Trial for Rezpegaldesleukin in Patients With Severe Alopecia Areata
Mar 5, 2024
04:04 PM EST, 03/05/2024 (MT Newswires) -- Nektar Therapeutics ( NKTR ) said Tuesday it started the phase 2b trial for rezpegaldesleukin to treat patients experiencing severe to very severe alopecia areata. The Phase 2b study will evaluate rezpegaldesleukin's efficacy and safety in 84 participants with severe alopecia areata over a 36-week period using a randomized, double-blind, placebo-controlled dosage, Nektar...
Berkshire's PacifiCorp ordered to pay $29.2 million to homeowners, summer camp for 2020 Oregon wildfire damage
Berkshire's PacifiCorp ordered to pay $29.2 million to homeowners, summer camp for 2020 Oregon wildfire damage
Mar 5, 2024
(Reuters) - An Oregon state jury on Tuesday ordered Berkshire Hathaway's ( BRK/A ) PacifiCorp ( PPWLM ) to pay at least $29.2 million to nine homeowners and a summer camp whose properties were damaged by 2020 wildfires they claim were sparked when the Oregon utility failed to shut off its power lines during high winds. The verdict came in...
Cancer Focused Immutep's Stock Soars On Tuesday - Here's Why
Cancer Focused Immutep's Stock Soars On Tuesday - Here's Why
Mar 5, 2024
Immutep Limited ( IMMP ) announces safety and initial efficacy data from the first ever 90mg dosing of eftilagimod alpha (efti) in combination with weekly paclitaxel in patients from the safety lead-in (N=6) of the AIPAC-003 Phase 2/3 trial. Updated safety data from patients with HR-positive/HER2-negative/low metastatic breast cancer (MBC) treated with this immuno-oncology (IO)-chemotherapy combination reveal no treatment-emergent serious adverse events. ...
Copyright 2023-2025 - www.financetom.com All Rights Reserved